Proton Pump Inhibitors Should be Used with Caution in Critically III Patients to Prevent the Risk of Clostridium difficile Infection

被引：2
作者：
Min, Jung Hwa [1 ]
Kim, You Sun [1 ]
机构：
[1] Inje Univ, Seoul Paik Hosp, Dept Internal Med, Coll Med, 9 Mareunnae Ro, Seoul 04551, South Korea
来源：
GUT AND LIVER | 2016年 / 10卷 / 04期
关键词：
METAANALYSIS; DIARRHEA;
D O I：
10.5009/gnl16216
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：493 / 494
页数：2
相关论文
共 11 条
[1]   Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically III Patients: A Systematic Review and Meta-Analysis [J].
Alhazzani, Waleed ;
Alenezi, Farhan ;
Jaeschke, Roman Z. ;
Moayyedi, Paul ;
Cook, Deborah J. .
CRITICAL CARE MEDICINE, 2013, 41 (03) :693-705
[2]   'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors? [J].
Atkinson, Nathan S. S. ;
Reynolds, D. John M. ;
Travis, Simon P. L. .
INTESTINAL RESEARCH, 2015, 13 (03) :227-232
[3]  
Burke KE, 2014, GUT LIVER, V8, P1, DOI [10.5009/gnl.2014.8.1.1, 10.5009/gn1.2014.8.1.1]
[4]   Long-Term Clinical Outcome of Clostridium difficile Infection in Hospitalized Patients: A Single Center Study [J].
Doh, Young Seok ;
Kim, You Sun ;
Jung, Hye Jin ;
Park, Young Il ;
Mo, Jin Won ;
Sung, Hyun ;
Lee, Kyung Jin ;
Seo, Young Ki ;
Moon, Jeong Seop ;
Hong, Seong Woo .
INTESTINAL RESEARCH, 2014, 12 (04) :299-305
[5]   A Case of Toxic Megacolon Caused by Clostridium difficile Infection and Treated with Fecal Microbiota Transplantation [J].
Gweon, Tae-Geun ;
Lee, Kyung Jin ;
Kang, Donghoon ;
Park, Sung Soo ;
Kim, Kyung Hoon ;
Seong, Hyeonjin ;
Ban, Tae-Hyun ;
Moon, Sung Jin ;
Kim, Jin Su ;
Kim, Sang Woo .
GUT AND LIVER, 2015, 9 (02) :247-250
[6]   Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis [J].
Janarthanan, Sailajah ;
Ditah, Ivo ;
Adler, Douglas G. ;
Ehrinpreis, Murray N. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (07) :1001-1010
[7]   Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study [J].
Kim, Y. S. ;
Han, D. S. ;
Kim, Y. H. ;
Kim, W. H. ;
Kim, J. S. ;
Kim, H. S. ;
Kim, H. S. ;
Park, Y. S. ;
Song, H. J. ;
Shin, S. J. ;
Yang, S. K. ;
Ye, B. D. ;
Eun, C. S. ;
Lee, K. M. ;
Lee, S. H. ;
Jang, B. I. ;
Jung, S. A. ;
Cheon, J. H. ;
Choi, C. H. ;
Huh, K. C. .
EPIDEMIOLOGY AND INFECTION, 2013, 141 (01) :189-194
[8]   Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis [J].
Kwok, Chun Shing ;
Arthur, Aaron Kobina ;
Anibueze, Chukwudubem Ifeanyichukwu ;
Singh, Sonal ;
Cavallazzi, Rodrigo ;
Loke, Yoon Kong .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (07) :1011-1019
[9]   Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003:: a changing pattern of disease severity [J].
Pépin, J ;
Valiquette, L ;
Alary, ME ;
Villemure, P ;
Pelletier, A ;
Forget, K ;
Pépin, K ;
Chouinard, D .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (05) :466-472
[10]   Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea:: A cohort study during an epidemic in Quebec [J].
Pépin, J ;
Saheb, N ;
Coulombe, MA ;
Alary, ME ;
Corriveau, MP ;
Authier, S ;
Leblanc, M ;
Rivard, G ;
Bettez, M ;
Primeau, V ;
Nguyen, M ;
Jacob, CE ;
Lanthier, L .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) :1254-1260
12